Market Overview

UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on ICON plc

Related ICLR
Healthways, Genesis Physicians Group Unite to Enhance Healthcare - Analyst Blog
PAREXEL's ClinPhone RTSM Cuts Clinical Trial Start-Up Time - Analyst Blog

In a report published Wednesday, Jefferies & Company reiterated its Buy rating on ICON plc (NASDAQ: ICLR), and raised its price target from $29.00 to $32.00.

Jefferies noted, “ICON's investor day focused on the competitive differentiation and margin leverage that should come from recent technology and informatics investments. With robust backlog growth, management's revenue outlook for 2013 appears conservative. Nonetheless, efficiency improvements, utilization, and centralized support should drive considerable margin improvement, likely to the 10%+ level before 2013 is over.”

ICON plc closed on Tuesday at $27.66.

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Most Popular

Related Articles (ICLR)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional